National Clinician Scholars Program, University of Pennsylvania, and Corporal Michael J. Crescenz Veterans Affairs (VA) Medical Center, Philadelphia (Kilaru); Center for Emergency Care Policy and Research, Department of Emergency Medicine (Kilaru, Lubitz, Perrone, Meisel), and Mixed Methods Research Lab, Department of Family Medicine and Community Health (Davis, Eriksen), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia (Perrone, Meisel); Hospital and Healthsystem Association of Pennsylvania, Harrisburg (Siegel); Office of Medical Assistance Programs, Pennsylvania Department of Human Services, Harrisburg (Kelley).
Psychiatr Serv. 2021 Sep 1;72(9):1048-1056. doi: 10.1176/appi.ps.202000501. Epub 2021 Feb 17.
In 2019, Pennsylvania established a voluntary financial incentive program designed to increase the engagement in addiction treatment for Medicaid patients with opioid use disorder after emergency department (ED) encounters. In this qualitative study involving hospital leaders, the authors examined decisions leading to participation in this program as well as barriers and facilitators that influenced its implementation.
Twenty semistructured interviews were conducted with leaders from a diverse sample of hospitals and health systems across Pennsylvania. Interviews were planned and analyzed following the Consolidated Framework for Implementation Research. An iterative approach was used to analyze the interviews and determine key themes and patterns regarding implementation of this policy initiative in hospitals.
The authors identified six key themes that reflected barriers and facilitators to hospital participation in the program. Participation in the program was facilitated by community partners capable of arranging outpatient treatment for opioid use disorder, incentive payments focusing hospital leadership on opioid treatment pathways, multidisciplinary planning, and flexibility in adapting pathways for local needs. Barriers to program participation concerned the implementation of buprenorphine prescribing and the measurement of treatment outcomes.
A financial incentive policy encouraged hospitals to enact rapid system and practice changes to support treatment for opioid use disorder, although challenges remained in implementing evidence-based treatment-specifically, initiation of buprenorphine-for patients visiting the ED. Analysis of treatment outcomes is needed to further evaluate this policy initiative, but new delivery and payment models may improve systems to treat patients who have an opioid use disorder.
2019 年,宾夕法尼亚州设立了一项自愿性财政激励计划,旨在增加在急诊(ED)就诊后接受阿片类药物使用障碍治疗的医疗补助患者参与度。在这项涉及医院领导的定性研究中,作者研究了导致参与该计划的决策,以及影响其实施的障碍和促进因素。
对宾夕法尼亚州不同医院和医疗系统的领导进行了 20 次半结构化访谈。访谈按照实施研究综合框架进行计划和分析。采用迭代方法对访谈进行分析,以确定该政策倡议在医院实施的关键主题和模式。
作者确定了六个关键主题,反映了医院参与该计划的障碍和促进因素。社区合作伙伴有能力为阿片类药物使用障碍安排门诊治疗,激励性支付使医院领导层关注阿片类药物治疗途径,多学科规划以及适应当地需求的灵活性,这些都促进了计划的参与。参与计划的障碍涉及丁丙诺啡处方的实施和治疗结果的衡量。
财政激励政策鼓励医院迅速实施系统和实践变革,以支持治疗阿片类药物使用障碍,尽管在实施基于证据的特定治疗方法(即丁丙诺啡的启动)方面仍存在挑战,针对就诊 ED 的患者。需要分析治疗结果,以进一步评估该政策倡议,但新的交付和支付模式可能会改善治疗阿片类药物使用障碍患者的系统。